Related Experiment Video

Updated: Jun 3, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

[Clinical study of pneumocystis pneumonia in patients with rheumatoid arthritis]

Yosuke Miyahara1, Noboru Takayanagi, Takashi Ishiguro

  • 1Department of Respiratory Medicine, Saitama Cardiovascular and Respiratory Center.

Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society
|March 10, 2011
PubMed

Insights

Pneumocystis pneumonia (PCP) can occur in rheumatoid arthritis patients using methotrexate or TNF inhibitors. Early detection is crucial as 25% of patients in this study died despite prompt treatment.

Area of Science:

  • Rheumatology
  • Infectious Diseases
  • Pulmonology

Context:

  • Rheumatoid arthritis (RA) patients are often immunocompromised due to their disease and treatments.
  • Pneumocystis pneumonia (PCP) is a serious opportunistic infection that can affect these patients.
  • Understanding PCP risk factors and outcomes in RA is critical for patient management.

Purpose:

  • To analyze cases of PCP in patients with rheumatoid arthritis.
  • To identify prognostic indicators for mortality in RA patients with PCP.
  • To assess the safety of reintroducing immunosuppressive therapy after PCP remission.

Summary:

  • This review examined 13 rheumatoid arthritis patients who developed Pneumocystis pneumonia (PCP).
  • Patients received treatments including methotrexate (MTX), corticosteroids, and TNF inhibitors.
  • Prognostic indicators for death included acute respiratory distress syndrome (ARDS), neutrophil/lymphocyte ratio, low albumin, elevated beta-D-glucan, and impaired oxygenation ratios (AaDO2, PaO2/FiO2).
  • Despite early PCP treatment, mortality was 25%, highlighting the severity of this infection in RA patients.

Impact:

  • Identifies key prognostic factors for PCP in RA patients, aiding clinical decision-making.
  • Suggests that PCP should be considered in RA patients experiencing respiratory symptoms, especially those on MTX or TNF inhibitors.
  • Provides insights into the potential for reintroducing immunosuppressive therapies post-PCP remission.

More Related Videos

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients07:25

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Published on: July 16, 2020

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...